← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2016-02-19

Drug application

FDA Application #

ANDA204841

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN

Generic name

SUMATRIPTAN

Active ingredients

SUMATRIPTAN

Dosage form

SPRAY

Route

NASAL

Marketing status

Prescription

Sponsor

LANNETT CO INC

Manufacturer

Lannett Company, Inc.

First approval

2016-02-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown